| January 2004 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
| Dec Feb | ||||||
For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.
C H A N N E L S
• PULSE Home
Page
•
EXECUTIVE
EDITION
•
US News
•
Canada
News
•
UK News
•
New
Zealand News
•
Consumer
Advocacy
•
Health
Care Systems
•
Managed
Care/Medicaid
•
Co-occurring
Disorders
•
Clinical
studies
•
Pharmaceutical
News
•
Criminal
Justice Systems
•
Legislative
News
U S E R ' S G
U I D E
About
PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE
E M A I L S
U B S C R I P T I O N S
For WEEKLY summaries
of PULSE postings, see the weekly
email subscription form.
For DAILY mailings (powered
by Bloglet), please enter your e-mail address below:
PULSE ANNUAL No. 2
January 2003
Recent
Trends, Challenges and Issues in Funding Public Mental Health Services
in the US
March 2002
PULSE ANNUAL No. 1
October 2001
PULSE is powered by
Radio Userland.
© Bill Davis, 2000-2003.
![]()
The Effectiveness of Telepsychiatry: A Review
Article in the latest Bulletin of the Canadian Psychiatric Association - "Effectiveness must be determined for each new technology because it may have advantages and disadvantages over what is currently offered. We reviewed the literature to synthesize information on whether telepsychiatry is effective. Based on the literature, we suggest that the effectiveness of telepsychiatry be evaluated on access to care, quality of care (that is, outcomes, reliability, satisfaction and comparison with in-person care), costs and empowerment. Further, we discuss other factors that influence effectiveness (for example, technology, administrative coordination and financial support). Telepsychiatry appears effective, and recommendations are offered for further evaluation of its effectiveness."
Riluzole Therapy Effective in Treatment-Resistant Depression
Medscape Medical News story - "Riluzole is associated with antidepressant effects in patients with treatment-resistant depression, according to results of an open-label study reported in the January issue of the American Journal of Psychiatry. Riluzole is a glutamate-modulating agent currently approved by the U.S. Food and Drug Administration for the treatment of amyotrophic lateral sclerosis." "med"![]()